1
|
Yu X, Ji X, Fan Y, Yu B, Wang X, Feng C, Zhang L, Song C, Zhang X. Static Magnetic Fields Protect against Cisplatin-Induced Kidney Toxicity. Antioxidants (Basel) 2022; 12:antiox12010073. [PMID: 36670933 PMCID: PMC9854588 DOI: 10.3390/antiox12010073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2022] [Revised: 12/26/2022] [Accepted: 12/27/2022] [Indexed: 01/01/2023] Open
Abstract
Cisplatin is one of the most widely used anti-cancer drugs that can effectively inhibit the growth of multiple types of cancer. However, its clinical application is limited by its severe side effects, especially kidney toxicity, caused by cisplatin-induced oxidative stress, inflammation and kidney cell apoptosis. Here, we found that moderate (a few hundred mT) quasi-uniform static magnetic fields (SMFs) could inhibit cisplatin-induced renal proximal tubular cell death, especially the vertically downward direction SMF. RNA-seq experiments demonstrate that SMFs induced differential gene expressions that are closely associated with oxidative stress, apoptosis, cytokine production, transmembrane transport and DNA repair. In vivo experiments show that SMFs can reduce cisplatin-induced kidney injury in cisplatin-administrated tumor-bearing mice by reducing oxidative stress, inflammation and cell apoptosis. Furthermore, high-dose cisplatin-induced acute nephrotoxicity can be effectively alleviated by SMF treatment of as little as one day, which significantly reduced the reactive oxygen species levels in kidneys and prolonged the mice's survival. Moreover, the concentration of cisplatin in the kidney was significantly attenuated in SMF-treated mice. Therefore, our study demonstrates the effects of moderate SMFs as a novel physical method to reduce oxidative stress, and revealed their future potential to be used against cisplatin-induced kidney toxicity in cancer treatment.
Collapse
Affiliation(s)
- Xin Yu
- High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- Science Island Branch of Graduate School, University of Science and Technology of China, Hefei 230036, China
| | - Xinmiao Ji
- High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
| | - Yixiang Fan
- High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- Science Island Branch of Graduate School, University of Science and Technology of China, Hefei 230036, China
| | - Biao Yu
- High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
| | - Xinyu Wang
- High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- Institutes of Physical Science and Information Technology, Anhui University, Hefei 230601, China
| | - Chuanlin Feng
- High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- Science Island Branch of Graduate School, University of Science and Technology of China, Hefei 230036, China
| | - Lei Zhang
- High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
| | - Chao Song
- High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- Correspondence: (C.S.); (X.Z.)
| | - Xin Zhang
- High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China
- Science Island Branch of Graduate School, University of Science and Technology of China, Hefei 230036, China
- Institutes of Physical Science and Information Technology, Anhui University, Hefei 230601, China
- International Magnetobiology Frontier Research Center, Science Island, Hefei 230036, China
- Correspondence: (C.S.); (X.Z.)
| |
Collapse
|
2
|
Low-Frequency Magnetic Field Exposure System for Cells Electromagnetic Biocompatibility Studies. APPLIED SCIENCES-BASEL 2022. [DOI: 10.3390/app12146846] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
The advancement in science and technology has resulted in the invention and widespread usage of many electrical devices in the daily lives of humans. The exponential use of modern electronic facilities has increased electromagnetic field exposure in the current population. Therefore, the presented article deals with designing, constructing, and testing a new applicator system developed for cells electromagnetic biocompatibility studies. The applicator system is intended for studying the non-thermal impacts of low-frequency magnetic field on cell cultures growth. Main attention is focused on increasing the capacity of the applicator and effectivity of the experiments. The key idea is to reach high level of the magnetic field homogeneity in an area of interest and the temperature stability during the biocompatibility studies. The applicator system is designed based on numerical simulations and its construction, measurements, and properties evaluation are also reported for proving the applicator’s functionality. The new applicator allows performing five parallel experiments at the same time under the same conditions. The simulation together with the experimental results confirm that the magnetic field homogeneity reaches 99% in the area of interest and the maximum temperature instability is lower than 2% during the experiments. The effectiveness of new applicator is tested and proved during preliminary experiments with Saccharomyces Cerevisiae cells. The observed effects of MF exposure represent maximal stimulation of 74% and maximal inhibition of 49%. The reason why MF with the same parameters induces inhibition in one sample and stimulation in the other will be the subject of further research.
Collapse
|
3
|
Xu A, Wang Q, Lv X, Lin T. Progressive Study on the Non-thermal Effects of Magnetic Field Therapy in Oncology. Front Oncol 2021; 11:638146. [PMID: 33816280 PMCID: PMC8010190 DOI: 10.3389/fonc.2021.638146] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2020] [Accepted: 02/08/2021] [Indexed: 12/16/2022] Open
Abstract
Cancer is one of the most common causes of death worldwide. Although the existing therapies have made great progress and significantly improved the prognosis of patients, it is undeniable that these treatment measures still cause some serious side effects. In this context, a new treatment method is needed to address these shortcomings. In recent years, the magnetic fields have been proposed as a novel treatment method with the advantages of less side effects, high efficiency, wide applications, and low costs without forming scars. Previous studies reported that static magnetic fields (SMFs) and low-frequency magnetic fields (LF-MFs, frequency below 300 Hz) exert anti-tumor function, independent of thermal effects. Magnetic fields (MFs) could inhibit cell growth and proliferation; induce cell cycle arrest, apoptosis, autophagy, and differentiation; regulate the immune system; and suppress angiogenesis and metastasis via various signaling pathways. In addition, they are effective in combination therapies: MFs not only promote the absorption of chemotherapy drugs by producing small holes on the surface of cell membrane but also enhance the inhibitory effects by regulating apoptosis and cell cycle related proteins. At present, MFs can be used as drug delivery systems to target magnetic nanoparticles (MNPs) to tumors. This review aims to summarize and analyze the current knowledge of the pre-clinical studies of anti-tumor effects and their underlying mechanisms and discuss the prospects of the application of MF therapy in cancer prevention and treatment.
Collapse
Affiliation(s)
- Aoshu Xu
- College of Instrumentation and Electrical Engineering, Jilin University, Changchun, China
- Key Laboratory of Geophysics Exploration Equipment, Ministry of Education of China, Changchun, China
| | - Qian Wang
- College of Instrumentation and Electrical Engineering, Jilin University, Changchun, China
- Key Laboratory of Geophysics Exploration Equipment, Ministry of Education of China, Changchun, China
| | - Xin Lv
- College of Instrumentation and Electrical Engineering, Jilin University, Changchun, China
- Key Laboratory of Geophysics Exploration Equipment, Ministry of Education of China, Changchun, China
| | - Tingting Lin
- College of Instrumentation and Electrical Engineering, Jilin University, Changchun, China
- Key Laboratory of Geophysics Exploration Equipment, Ministry of Education of China, Changchun, China
| |
Collapse
|
4
|
Static magnetic field enhances the anticancer efficacy of capsaicin on HepG2 cells via capsaicin receptor TRPV1. PLoS One 2018; 13:e0191078. [PMID: 29338036 PMCID: PMC5770067 DOI: 10.1371/journal.pone.0191078] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2017] [Accepted: 12/26/2017] [Indexed: 12/22/2022] Open
Abstract
Static magnetic field (SMF) has shown some possibilities for cancer therapies. In particular, the combinational effect between SMF and anti-cancer drugs has drawn scientists’ attentions in recent years. However, the underlying mechanism for the drug-specific synergistic effect is far from being understood. Besides, the drugs used are all conventional chemotherapy drugs, which may cause unpleasant side effects. In this study, our results demonstrate for the first time that SMF could enhance the anti-cancer effect of natural compound, capsaicin, on HepG2 cancer cells through the mitochondria-dependent apoptosis pathway. We found that the synergistic effect could be due to that SMF increased the binding efficiency of capsaicin for the TRPV1 channel. These findings may provide a support to develop an application of SMF for cancer therapy. The present study offers the first trial in combining SMF with natural compound on anti-cancer treatment, which provides additional insight into the interaction between SMF and anti-cancer drugs and opens the door for the development of new strategies in fighting cancer with minimum cytotoxicity and side effects.
Collapse
|
5
|
Szwed M, Kania KD, Jozwiak Z. Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin. Cell Oncol (Dordr) 2014; 37:421-8. [PMID: 25410120 PMCID: PMC4255090 DOI: 10.1007/s13402-014-0205-5] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/17/2014] [Indexed: 11/26/2022] Open
Abstract
BACKGROUND Conjugation of anti-neoplastic agents with human proteins is a strategy to diminish the toxic side effects of anthracycline antibiotics. We have developed a novel doxorubicin-transferrin (DOX-TRF) conjugate aimed to direct anticancer drugs against therapeutic targets that display altered levels of expression in malignant versus normal cells. Our previous work has shown that the cellular bio-distribution of the conjugate is dependent on a dynamic balance between influx and efflux processes. Here, we set out to investigate whether P-glycoprotein (P-gp) expression may affect DOX-TRF conjugate-induced cellular drug accumulation and cytotoxicity. RESULTS All experiments were carried out on human erythromyeloblastoid cells exhibiting P-gp over-expression (K562/DOX) and its drug sensitive parental line (K562). MTT cytotoxicity, flow cytometry, fluorescence microscopy and RT-PCR assessments revealed that the investigated conjugate (DOX-TRF) possesses a greater cytotoxic potential than free DOX. CONCLUSION Our data suggest that the newly developed DOX-TRF conjugate is a less P-gp dependent substrate than free DOX and, consequently, may be used in a clinical setting to increase treatment efficacy in resistant human tumors.
Collapse
Affiliation(s)
- Marzena Szwed
- Department of Thermobiology, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143 Street, 90-236, Lodz, Poland,
| | | | | |
Collapse
|